Innoviz Technologies Ltd. has announced a significant corporate action: a 1-for-20 reverse share split of its ordinary shares. This decision is intended to increase the per-share trading price of its stock, helping the company regain compliance with Nasdaq's minimum bid price requirement of $1.00. The reverse split is set to become effective on December 4, 2026, with trading on a split-adjusted basis beginning December 7, 2026.
The reverse share split comes after the company’s shareholders approved the measure during the annual general meeting held on September 16, 2026. The board of directors was authorized to determine the specific ratio of the split, which ultimately was set at 1-for-20. This strategic move reflects Innoviz's ongoing efforts to align its capital structure with market expectations and regulatory compliance.
Background
Innoviz Technologies Ltd. is a prominent player in the motor vehicle parts and accessories sector, specifically known for its high-performance LiDAR sensor platforms. The company is publicly traded on the Nasdaq under the ticker symbol INVZ. Innoviz operates primarily in the automotive, security, defense, and industrial markets, providing advanced sensing solutions designed to meet stringent performance and safety standards.
What the Filing Says
According to the recent filing, "On November 18, 2026, Innoviz Technologies Ltd. ... announced a 1-for-20 reverse share split of its ordinary shares..." The filing also noted that the authorized share capital would be reduced from 500 million to 25 million ordinary shares. This action is aimed at increasing the trading price of the shares to comply with Nasdaq listing requirements.
Impact
The reverse share split will reduce the number of outstanding shares from approximately 299.5 million to about 15 million. This change will affect all shareholders uniformly, although those holding fewer than twenty shares will receive cash payments instead of fractional shares. The move is expected to help Innoviz stabilize its stock price and maintain its listing on Nasdaq, which is crucial for investor confidence and market visibility.
What's Next
The filing does not say what happens next.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










